Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2020 | PRECISION-Panc: platform to enhance biomarker discovery for pancreatic cancer

David Chang • 16 Oct 2020
ESMO 2020
Pancreatic Cancer

David Chang, MBBS, FRACS, PhD, University of Glasgow, Glasgow, UK, outlines the PRECISION-Panc project, designed to bring together key stakeholders in the treatment of pancreatic cancer in the UK, at the ESMO 2020 education weekend. Dr Chang describes how the platform, which is majority funded by Cancer Research UK, can contribute towards the improvement of precision medicine by enhancing biomarker discovery and development. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from David Chang

2:21
Pan-cancer analysis of whole genomes
David Chang • 16 Oct 2020
2:39
Experience of setting up the PRECISION-Panc platform
David Chang • 16 Oct 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:16
Entinostat with nivolumab in pancreatic ductal adenocarcinoma
Marina Baretti • 9 Apr 2024
0:40
The limited therapeutic efficacy of checkpoint inhibitors for pancreatic cancer
Olatunji Alese • 8 Apr 2024
0:48
Siltuximab and spartalizumab in advanced pancreatic adenocarcinoma
Olatunji Alese • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals